ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001

Prominent Duke Scientist Claimed Prizes He Didn’t Win, Including Rhodes Scholarship

July 16, 2010

New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training

June 20, 1986

Beckman Coulter Offers Immunoassay System.

July 27, 2001

Zerhouni Appoints Two Institute Directors

September 13, 2002

Research Budget Falls Flat: Bush Proposes 0.68 Percent Raise for NIH, 0.35 Percent Increase for NCI. Bush Seeks 4.5 Percent Increase for FDA, 6 Percent Cut for CDC.

February 11, 2005